Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™)

Launched by AO CLINICAL INVESTIGATION AND PUBLISHING DOCUMENTATION · Dec 1, 2014

Keywords

ClinConnect Summary

In comparison to previous implants, the TFNA has been improved substantially. Therefore the purpose of this focused registry is to investigate how the newly developed implant called Trochanteric Fixation Nailing with anti-rotation feature (TFNA) is performing clinically and radiologically in terms of surgical technique, intra- and postoperative complications and short term outcome.

All investigated procedures are part of the standard of care treatment. Only the parker mobility score is study-specific. All patients included are followed up from the time point of enrollment until three month...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 years and older
• • Pertrochanteric femoral fracture (31-A1 and 31-A2), intertrochanteric fracture (31-A3), fracture of the trochanteric area (31-A1/A2/A3) with diaphyseal extension or combined fracture of the trochanteric area and the femoral shaft (32-A/B/C) treated with the TFNA system according to the technique guide
• • Ability to understand the content of the patient information / informed consent form
• • Willingness and ability to participate in the registry according to the registry plan (RP)
• • Signed and dated IRB/EC-approved written informed consent or assent from a family member
• Exclusion Criteria:
• • Additional acute fracture
• • Any not medically managed severe systemic disease
• • Recent history of substance abuse (i.e., recreational drugs, alcohol) that would preclude reliable assessment
• • Pregnancy or women planning to conceive within the registry period
• • Prisoner
• • Participation in any other medical device or medicinal product registry within the previous month that could influence the results of the present registry
• • Intraoperative decision to use implants other than the devices under investigation

Trial Officials